Category: Disorders & Diseases

Disorders & Diseases

DPP-1 Inhibitors Aim to Reduce Bronchiectasis Flare-Ups

A new class of drugs offers a disease-based approach to managing non-cystic fibrosis bronchiectasis by targeting airway inflammation.

Disorders & Diseases

Tech-funded Project Intercept Aims to Strike Down Cold and Flu

Backed by approximately $500 million in investment from Big Tech, the Intercept initiative will back broad-spectrum preventatives and air-cleaning technologies to reduce the global health burden of respiratory infections.

Disorders & Diseases

Lung Cancer Survival Rates ‘Improving for Everyone,’ National Report Reveals

The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.

Chronic Pulmonary Disorders

How Genetic Mutations Cause Primary Ciliary Dyskinesia

An imaging study reveals how gene mutations impair airway clearance and lead to primary ciliary dyskinesia (PCD).

Infectious Diseases

FDA Approves Capvaxive Pneumococcal Vaccine for Children 2-17

The USFDA approved an expanded indication for Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) to include children and adolescents aged 2 through 17 years, according to Merck.

Critical Care

FDA Approves OTC Rextovy for Opioid Overdose

Rextovy, a 4 mg naloxone medication, will be available for purchase without a prescription at retail stores and online.

Cardiopulmonary & Thoracic

Sleep, Exercise Reduce CV Risk From Mutated White Blood Cells

Healthy lifestyle habits can repress the inflammatory effects of genetic mutations in white blood cells common in seniors.

Sleep Medicine

Monash, Brigham and Women’s Renew Sleep Research Partnership

The collaboration will focus on sleep and circadian medicine, including research into obstructive sleep apnea and wearable health technology.